Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
about
Human cytomegalovirus resistance to antiviral drugsHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsAntiviral drug resistance of human cytomegalovirus.How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.Cytomegalovirus drug resistance and clinical implications.Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology.Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibilityRole of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samplesPhenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivoDrug-resistant cytomegalovirus in transplant recipients: a French cohort study.Rapid detection of human cytomegalovirus UL97 and UL54 mutations for antiviral resistance in clinical specimens.Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature.Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
P2860
Q24556634-CA489EBA-4005-4931-AFC4-3C1AB6DE28EDQ28069489-10AFCC24-ACFF-4379-A151-993E10FB3BB7Q30430427-D24CA05D-1DB0-4A58-B56C-560536737638Q33592427-5DEDB472-3419-496E-905F-AC552864944CQ33876672-71BA8BE3-3BB5-42F6-83FD-ABF6FB8CA63EQ34439235-4EB6DA1A-CA23-40B7-9533-18A06C2C5A89Q34583495-475F9205-753E-4546-BC1D-94BE83FEC62DQ34670354-564821EC-3FE0-46AF-BB5E-D70BB3C187DEQ35385659-297694BB-DA66-409C-8FFF-32B9F7964CDDQ35635817-3D85AD0C-F7C3-4E69-8007-2DE684F0BBE5Q35692301-5BBA14A8-B3FA-45B5-8919-8E5999033F0FQ37713957-393E55F7-545A-48C9-9430-4B42F84DC156Q39626863-CE184B1F-28CF-45A1-93CE-B061E26FF9FEQ40399325-6D809211-ADC8-4A3C-9B60-BA6B663169D1Q41430486-0857C98C-7684-48A3-9466-A3EBE52399A6Q41852563-5D360D2C-2D81-4772-93FD-A6540218FE36Q41880732-78A18FA7-F251-494A-84A0-9680C26E00B3Q42094851-8D317561-BA95-4414-8BD4-68BAA2E54F11Q42141568-248B1922-FF87-454B-B8BD-71238D4293FAQ42852632-EA181BDE-A23B-4F8B-8E7E-17E73C62D548Q43644735-C0097B39-6C07-4159-8F79-3847576204CFQ43751129-2A778446-9249-4834-AADD-3F022CAE4DF5Q46490890-9F96944C-0D3F-4B81-BCEF-613AB7F0FE96Q47333098-FA421952-5B73-4F4E-8B94-7ABAB88F0F63Q48039802-1A0FEBC5-566B-41A4-A396-2F722F16C271
P2860
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@en
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@nl
type
label
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@en
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@nl
prefLabel
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@en
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@nl
P2093
P2860
P1476
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.
@en
P2093
A Weinberg
Adult AIDS Clinical Trials Group-CMV Laboratories
C S Crumpacker
N S Lurain
P2860
P304
P356
10.1128/AAC.45.10.2775-2780.2001
P407
P577
2001-10-01T00:00:00Z